Sanofi and Teva's inflammatory disease drug meets main goals in mid-stage trial-February 2024-www.financetom.com

Sanofi and Teva's inflammatory disease drug meets main goals in mid-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sanofi and Teva's inflammatory disease drug meets main goals in mid-stage trial

Dec 17, 2024 5:02 AM

Dec 17 (Reuters) - Sanofi and Teva

Pharmaceuticals said on Tuesday that their drug met

the main goals in a mid-stage trial, when tested in patients

with inflammatory bowel disease.

Previous page： Sula Vineyards expects bumper harvest in early 2024 Next page： UltraTech Cement acquires Burnpur Cement's grinding assets in Jharkhand for ₹170 crore

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sula Vineyards expects bumper harvest in early 2024

Nov 29, 2023

The unseasonal rainfall in Mumbai and other parts of the state prompted concerns about potential disruptions in the agricultural supply chain.

UltraTech Cement acquires Burnpur Cement's grinding assets in Jharkhand for ₹170 crore

Nov 29, 2023

This acquisition not only substantially hikes UltraTech Cement's capacity but also serves as a strategic entry into the promising market of Jharkhand. Shares of UltraTech Cement Ltd ended at ₹8,721.80, down by ₹6.20, or 0.071%, on the BSE.

Cult US sneaker brand Foot Locker inks exclusive licensing deal with Metro Brands & Nykaa

Nov 29, 2023

The volume of the sneaker segment in India is projected to reach 66 million pairs by 2028. Shares of Metro Brands Ltd ended at ₹1,326.85, up by ₹27.10, or 2.09%, and shares of FSN E-Commerce Ventures Ltd ended at ₹172.10, up by ₹2.80, or 1.65%, on the BSE.

Axis Mutual Fund eyes ₹3 lakh crore AUM by March, expects ₹2,500 crore from new fund

Nov 29, 2023

The fund house opened the year with an AUM (assets under management) of over ₹2.25 lakh crore. The open-ended equity scheme represents the manufacturing theme and opens for subscription on December 1 and closes on December 15.